TOKYO -- Japan's government plans to cover compensation for any health problems that may arise here from coronavirus vaccines, seeking to ensure a stable supply from foreign manufacturers as global competition intensifies, Nikkei has learned.
Pharmaceuticals
Japan to shoulder COVID vaccine liability risks
Government to compensate for side effects, in bid to secure stable supply
Nearly 30 coronavirus vaccine candidates have entered clinical trials, according to the World Health Organization, as drugmakers compress their development timelines. (Photo by Tomoki Mera)
Read Next
Latest on Pharmaceuticals
